US Stem Cell Inc (USRM)

[mdub]

it is going to be 3 months after the last patient gets the treatment. they are going to measure 6 minute walking distance which has been their standard measure, and is a commonly used measure of cardiac function in patients with heart failure. it does not matter when they started the trial, all that matters is when the last patient enrolled gets the treatment. after that they will have press releases at 3, 6, and 12 months comparing the myocell to whatever is the current standard of care.